ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Editorial
Development of Harmonized Bioanalytical Method Validation Guidelines
DOI: 10.4172/jbb.10000e39
The New Generation of Drug Discovery and its Analytical Technologies
DOI: 10.4172/jbb.10000e42
The Impact of Physical Processes and Chemicals of the Antioxidants (Bioactivity Compounds)
DOI: 10.4172/jbb.10000e44
Biosimilars: The New Era of Drug Development?
DOI: 10.4172/jbb.10000e40
Research Article
Dissolution Effect of Gastric and Intestinal pH fora BCS class II drug, Pioglitazone: New in vitro Dissolution System to Predict in vivo Dissolution
DOI: 10.4172/jbb.1000162
Development and Validation of LC-MS/MS Method for Determination of Testosterone Level in Human Saliva Using Lovastatin as Internal Standard
DOI: 10.4172/jbb.1000163
Review Article
Transdermal Application of Drugs and Techniques Affecting Skin Barrier
DOI: 10.4172/jbb.1000164
P-gp Induction by Curcumin: An Effective Antidotal Pathway
DOI: 10.4172/jbb.1000165
Short Communication
Suggestions for the Preliminary Definition of a Current Background Profile of Polychlorodibenzodioxin (PCDDs) and Polychlorodibenzofuran (PCDFs) Congeners in Serum Samples
DOI: 10.4172/jbb.1000166
Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry
DOI: 10.4172/jbb.1000167